Antiangiogenic Potential of Pomegranate Extracts

Area of Science:

• Phytochemistry
• Pharmacology
• Oncology

Background:

• Pomegranate (Punica granatum L.) is recognized for its antioxidant properties.
• Emerging research indicates pomegranate possesses antiangiogenic potential, crucial for inhibiting pathological blood vessel formation.
• This is relevant for conditions like cancer and other angiogenesis-driven disorders.

Purpose of the Study:

• To review current findings on the antiangiogenic effects of pomegranate extracts.
• To explore the impact of pomegranate's bioactive compounds on angiogenesis pathways.
• To discuss the utilization of pomegranate by-products for sustainable extract preparation.

Main Methods:

• Review of in vitro and in vivo preclinical studies.
• Analysis of pomegranate polyphenols (ellagic acid, punicalagin, anthocyanins, punicic acid) and polysaccharides.
• Focus on phytocomplex effects rather than isolated compounds.

Main Results:

• Pomegranate extracts modulate key angiogenesis-related pathways and endothelial cell function.
• Bioactive compounds in pomegranate influence tumor growth and pathological angiogenesis.
• By-products like peels and seeds offer sustainable sources for potent extracts.

Conclusions:

• Pomegranate extracts exhibit promising antiangiogenic properties with potential therapeutic applications.
• Further research is needed to elucidate clinical utility, particularly as adjunctive cancer therapies.
• Sustainable sourcing from by-products enhances extract efficacy and environmental value.